Adiponectin: Spectator or player?

Stroke

Volumn 36, Issue 9, 2005, Pages 1919-1920

  Clark, Wayne M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Inflammation; Risk factors

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; FIBRINOGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; PHOSPHOLIPASE A2;

CEREBROVASCULAR ACCIDENT; HUMAN; INFLAMMATION; MORTALITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NOTE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RATING SCALE; RISK FACTOR;

EID: 24644445569     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/str.36.9.1919     Document Type: Note

References (10)

1. Efstathiou SP, Tsioulos DI, Tsiakou AG, Gratsias YE, Pefanis AV, Mountokalakis TD. Plasma adiponectin levels and 5-year survival after first-ever ischemic stroke. Stroke. 2005;36:1915-1919.
2. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab. 2004;89:2563-2568.
3. Pischon CJ, Girman GS, Hotamisligil GS. Plasma apidonectin levels and risk of myocardial infarction in men. JAMA. 2004;291:1730-1737.
4. Clark WM. Cytokines and reperfusion injury. Neurology. 1997;49(suppl 4):S10-S14.
5. Beamer NB, Coull BM, Clark WM, Briley DP, Wynn M, Sexton G. Persistent inflammatory response in stroke survivors. Neurology. 1998;50:1722-1728.
6. Bassuk SS, Rifai N, Riker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 2004;29:439-493.
7. Packard CJ, O'Reilly DS, Caslake MJ. Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease: West of Scotland Coronary Prevention Study Group. N Engl J Med. 2000;343:1148-1155.
8. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767-1772.
9. Ridker PM, Hennekens CH, Roitman-Johnson B, Stamfer MJ, et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet. 1998;351:88-92.
10. Beamer NB, Coull BM, Clark WM, Hazel JS, Silberger JR. Interleukin-6 and interleukin-1 receptor antagonist in acute stroke. Ann Neurol. 1995;6:801-805.